Thymia
The company provides a foundational voice biomarker platform that extracts over 30 clinical and wellbeing signals from 15 seconds of speech in real time. Its technology identifies indicators for mental health, respiratory, and cardiovascular conditions to prevent crises across healthcare, automotive, and safety-critical industries. The platform serves as an infrastructure layer for telehealth providers, AI agents, contact centers, and emergency services.
Visit websiteLondon, UK
Healthtech
Artificial Intelligence
Automotive
Telecommunications
Software Infrastructure
Funding summary
- Total raised
- €3.3M
- Funding rounds
- 2
Investors in Thymia
Investors on record for Thymia. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Thymia?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors